Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes

Clinical trial NCT07772960 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07772960
Sponsor: Yale University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alcohol Use Disorder (AUD)Obesity (BMI Equal to or >30)

Start date: 2026-10-01
Primary completion: 2031-10-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.